Trinity Biotech (TRIB) Competitors $0.80 +0.02 (+2.17%) As of 10:05 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TRIB vs. TNYA, OKYO, RNTX, ANEB, AADI, APLT, BLUE, COEP, DYAI, and STTKShould you be buying Trinity Biotech stock or one of its competitors? The main competitors of Trinity Biotech include Tenaya Therapeutics (TNYA), OKYO Pharma (OKYO), Rein Therapeutics (RNTX), Anebulo Pharmaceuticals (ANEB), Aadi Bioscience (AADI), Applied Therapeutics (APLT), bluebird bio (BLUE), Coeptis Therapeutics (COEP), Dyadic International (DYAI), and Shattuck Labs (STTK). These companies are all part of the "pharmaceutical products" industry. Trinity Biotech vs. Tenaya Therapeutics OKYO Pharma Rein Therapeutics Anebulo Pharmaceuticals Aadi Bioscience Applied Therapeutics bluebird bio Coeptis Therapeutics Dyadic International Shattuck Labs Tenaya Therapeutics (NASDAQ:TNYA) and Trinity Biotech (NASDAQ:TRIB) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, community ranking, institutional ownership and dividends. Which has more volatility & risk, TNYA or TRIB? Tenaya Therapeutics has a beta of 2.98, suggesting that its stock price is 198% more volatile than the S&P 500. Comparatively, Trinity Biotech has a beta of 1.21, suggesting that its stock price is 21% more volatile than the S&P 500. Which has preferable valuation & earnings, TNYA or TRIB? Trinity Biotech has higher revenue and earnings than Tenaya Therapeutics. Tenaya Therapeutics is trading at a lower price-to-earnings ratio than Trinity Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTenaya TherapeuticsN/AN/A-$124.08M-$1.32-0.37Trinity Biotech$59.13M0.24-$24.02M-$2.26-0.35 Does the media favor TNYA or TRIB? In the previous week, Tenaya Therapeutics had 4 more articles in the media than Trinity Biotech. MarketBeat recorded 6 mentions for Tenaya Therapeutics and 2 mentions for Trinity Biotech. Trinity Biotech's average media sentiment score of 1.44 beat Tenaya Therapeutics' score of 0.36 indicating that Trinity Biotech is being referred to more favorably in the news media. Company Overall Sentiment Tenaya Therapeutics Neutral Trinity Biotech Positive Do insiders & institutionals believe in TNYA or TRIB? 90.5% of Tenaya Therapeutics shares are owned by institutional investors. Comparatively, 79.0% of Trinity Biotech shares are owned by institutional investors. 32.8% of Tenaya Therapeutics shares are owned by insiders. Comparatively, 8.2% of Trinity Biotech shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the MarketBeat Community favor TNYA or TRIB? Trinity Biotech received 292 more outperform votes than Tenaya Therapeutics when rated by MarketBeat users. However, 84.31% of users gave Tenaya Therapeutics an outperform vote while only 70.23% of users gave Trinity Biotech an outperform vote. CompanyUnderperformOutperformTenaya TherapeuticsOutperform Votes4384.31% Underperform Votes815.69%Trinity BiotechOutperform Votes33570.23% Underperform Votes14229.77% Is TNYA or TRIB more profitable? Tenaya Therapeutics has a net margin of 0.00% compared to Trinity Biotech's net margin of -34.39%. Trinity Biotech's return on equity of 0.00% beat Tenaya Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Tenaya TherapeuticsN/A -86.17% -71.14% Trinity Biotech -34.39%N/A -21.37% Do analysts prefer TNYA or TRIB? Tenaya Therapeutics currently has a consensus target price of $6.25, indicating a potential upside of 1,188.66%. Given Tenaya Therapeutics' stronger consensus rating and higher possible upside, equities research analysts clearly believe Tenaya Therapeutics is more favorable than Trinity Biotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tenaya Therapeutics 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00Trinity Biotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryTenaya Therapeutics beats Trinity Biotech on 11 of the 17 factors compared between the two stocks. Get Trinity Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for TRIB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TRIB vs. The Competition Export to ExcelMetricTrinity BiotechDiagnostic substances IndustryMedical SectorNASDAQ ExchangeMarket Cap$14.44M$2.55B$5.51B$7.93BDividend YieldN/A0.75%5.11%4.22%P/E Ratio-0.357.6222.5518.49Price / Sales0.2450.05394.97102.66Price / CashN/A15.7538.1834.62Price / Book-0.253.746.694.25Net Income-$24.02M-$65.73M$3.22B$248.31M7 Day Performance24.98%0.29%1.11%1.12%1 Month Performance40.35%-2.05%3.59%3.68%1 Year Performance-54.29%-10.80%15.65%5.19% Trinity Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TRIBTrinity Biotech1.6667 of 5 stars$0.80+2.2%N/A-57.0%$14.44M$59.13M-0.35480Analyst ForecastShort Interest ↓Positive NewsGap UpTNYATenaya Therapeutics3.7799 of 5 stars$0.46+1.8%$6.25+1,264.0%-89.5%$40.13MN/A-0.32110Short Interest ↓OKYOOKYO Pharma2.7726 of 5 stars$1.17-4.1%$7.00+498.3%+5.7%$39.59MN/A0.007Short Interest ↓News CoverageGap UpRNTXRein TherapeuticsN/A$1.78+4.7%N/AN/A$39.15MN/A-0.579News CoverageANEBAnebulo Pharmaceuticals2.018 of 5 stars$0.95-5.9%$8.00+742.1%-58.3%$39.03MN/A-3.394Short Interest ↑News CoverageGap UpAADIAadi BioscienceN/A$1.57+1.9%$1.67+6.2%-22.9%$38.77M$25.07M-0.6940Upcoming EarningsAPLTApplied Therapeutics4.0809 of 5 stars$0.33-0.1%$6.10+1,734.0%-90.7%$38.70M$455,000.00-0.2130Upcoming EarningsNews CoveragePositive NewsBLUEbluebird bio3.0006 of 5 stars$3.90-5.8%$44.60+1,043.6%-77.0%$38.18M$83.81M-0.10520Upcoming EarningsAnalyst ForecastGap DownCOEPCoeptis Therapeutics1.1144 of 5 stars$11.20+12.0%N/A+34.9%$37.69MN/A-1.932Short Interest ↓DYAIDyadic International2.8826 of 5 stars$1.25+1.6%$6.00+380.0%-14.7%$37.61M$3.50M-5.437Short Interest ↓STTKShattuck Labs2.5606 of 5 stars$0.79+1.5%$7.50+855.3%-90.6%$37.61M$5.72M-0.51100Positive News Related Companies and Tools Related Companies Tenaya Therapeutics Competitors OKYO Pharma Competitors Rein Therapeutics Competitors Anebulo Pharmaceuticals Competitors Aadi Bioscience Competitors Applied Therapeutics Competitors bluebird bio Competitors Coeptis Therapeutics Competitors Dyadic International Competitors Shattuck Labs Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TRIB) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trinity Biotech plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Trinity Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TRIB Stock Free TRIB Stock Alerts